MedTrace Logo

Message Testing for Tobacco-Related Corrective Statements

NCT01282008 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 627

Last updated 2019-12-20

No results posted yet for this study

Summary

BACKGROUND:

This document outlines the study design and procedures to be used to evaluate a series of corrective statements to augment consumer knowledge and beliefs about smoking as related to past actions of tobacco companies. The statements were ordered by a U.S. Federal Court in U.S. v. Philip Morris USA, Inc., and are intended to target potential misperceptions resultant of past marketing and promotion practices undertaken by the tobacco industry.

OBJECTIVES:

The U.S. Department of Justice has asked NCI to take the lead on developing and testing corrective statements with adult and youth audiences to ensure both message comprehension and avoidance of unintended consequences of message exposure, such as boomerang effects, smoking triggers, or knowledge gaps.

The court has identified five areas that the statements shall address:

1. The adverse health effects of smoking;
2. The addictiveness of smoking and nicotine;
3. The lack of any significant health benefit from smoking low tar, light, ultra light, mild, and natural cigarettes;
4. The tobacco industry s manipulation of cigarette design and composition to ensure optimum nicotine delivery;
5. The adverse health effects of secondhand smoke.

ELIGIBILITY:

Message testing will be undertaken with the following audiences:

* Current smokers (with an oversample of low socioeconomic status individuals)
* General population nonsmokers and former smokers (with an oversample of low socioeconomic status individuals)
* Spanish-speaking Hispanics
* Youth age 14-17

DESIGN:

Both qualitative and quantitative methods (focus groups and post-test comparison group Web-enabled surveys) will be used to develop and test a range of corrective statements in the five areas outlined by the court.

* Focus group participants: 48-64
* Survey participants: 2500

Conditions

  • Tobacco
  • Smoking
  • Communication

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Kelly D Blake, D.Sc. · National Cancer Institute (NCI)

Eligibility

Min Age
14 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01282008 on ClinicalTrials.gov